Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.
Hannes Kettner, Fernando E. Rosas, C. Timmermann, Laura Kärtner, R. L. Carhart-Harris, Leor Roseman
Frontiers in Pharmacology March 25, 2021 DOI: 10.3389/fphar.2021.623985 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational web-based survey study Peer reviewed |
|---|---|
| Sample size | 886 |
| Population | Participants in psychedelic ceremonies and retreats |
| Duration | Five time-points: 2 weeks before, hours before, and the day after a psychedelic ceremony, plus the day after and 4 weeks after leaving the ceremony location |
| Measures | Communitas Scale, visual experiences questionnaire, mystical experiences questionnaire, challenging experiences questionnaire, perceived emotional synchrony, identity fusion, psychological wellbeing, social connectedness |
| Keywords | Mental health Wellbeing Collective experience Social connectedness Psychedelics Communitas Set and setting Ceremony |
| Citations | 205 |
| Key findings | The adapted Communitas Scale showed strong internal consistency and construct validity. Communitas during ceremony correlated with increases in psychological wellbeing (r = 0.22) and social connectedness (r = 0.25), and its effect on long-term outcomes was fully mediated by communitas toward the retreat overall. The authors argue that participant-facilitator rapport and emotional support facilitate communitas and matter for long-term outcomes. |
Abstract
Background: Recent years have seen a resurgence of research on the potential of psychedelic substances to treat addictive and mood disorders. Historically and contemporarily, psychedelic studies have emphasized the importance of contextual elements ('set and setting') in modulating acute drug effects, and ultimately, influencing long-term outcomes. Nevertheless, current small-scale clinical and laboratory studies have tended to bypass a ubiquitous contextual feature of naturalistic psychedelic use: its social dimension. This study introduces and psychometrically validates an adapted Communitas Scale, assessing acute relational experiences of perceived togetherness and shared humanity, in order to investigate psychosocial mechanisms pertinent to psychedelic ceremonies and retreats.
Methods: In this observational, web-based survey study, participants (N = 886) were measured across five successive time-points: 2 weeks before, hours before, and the day after a psychedelic ceremony; as well as the day after, and 4 weeks after leaving the ceremony location. Demographics, psychological traits and state variables were assessed pre-ceremony, in addition to changes in psychological wellbeing and social connectedness from before to after the retreat, as primary outcomes. Using correlational and multiple regression (path) analyses, predictive relationships between psychosocial 'set and setting' variables, communitas, and long-term outcomes were explored.
Results: The adapted Communitas Scale demonstrated substantial internal consistency (Cronbach's alpha = 0.92) and construct validity in comparison with validated measures of intra-subjective (visual, mystical, challenging experiences questionnaires) and inter-subjective (perceived emotional synchrony, identity fusion) experiences. Furthermore, communitas during ceremony was significantly correlated with increases in psychological wellbeing (r = 0.22), social connectedness (r = 0.25), and other salient mental health outcomes. Path analyses revealed that the effect of ceremony-communitas on long-term outcomes was fully mediated by communitas experienced in reference to the retreat overall, and that the extent of personal sharing or 'self-disclosure' contributed to this process. A positive relationship between participants and facilitators, and the perceived impact of emotional support, facilitated the emergence of communitas.
Conclusion: Highlighting the importance of intersubjective experience, rapport, and emotional support for long-term outcomes of psychedelic use, this first quantitative examination of psychosocial factors in guided psychedelic settings is a significant step toward evidence-based benefit-maximization guidelines for collective psychedelic use.
Citations in the library
Cited by 178
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
- Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression Frontiers in Pharmacology March 31, 2022
- Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review Neuroscience & Biobehavioral Reviews September 1, 2022
- Psychedelics alter metaphysical beliefs. Scientific Reports November 23, 2021
- The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world Psychopharmacology August 8, 2022
and 173 more in the library
Cites 81
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 76 more in the library